Why is the interferon sensitivity-determining region (ISDR) system useful in Japan?

Journal of Hepatology

Volumn 30, Issue 6, 1999, Pages 1014-1022

  Nakano, Isao ^a   Fukuda, Yoshihide ^a   Katano, Yoshiaki ^a   Nakano, Satoshi ^b   Kumada, Takashi ^b   Hayakawa, Tetsuo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Genotype 1b; Geographical difference; Hepatitis C virus; Interferon responsiveness; Interferon sensitivity determining region (ISDR)

Indexed keywords

INTERFERON;

AMINO ACID SEQUENCE; ARTICLE; DRUG RESPONSE; DRUG SENSITIVITY; ETHNIC DIFFERENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL;

EID: 0033002009     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80254-2     Document Type: Article

References (26)

1. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellelar carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 12:1990;671-675.
2. Houghton M, Weiner A, Hann J, Kuo G, Choo QL. Review: molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 14:1991;381-388.
3. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 15:1995;41-63.
4. Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci USA. 90:1993;8234-8238.
5. Tsubota A, Chayama K, Ikeda K, Arase Y, Koida I, Saitoh S, et al. Factors predictive of response to interferon-alfa therapy in hepatitis C virus infection. Hepatology. 19:1994;1088-1094.
6. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. J Clin Invest. 96:1995;224-230.
7. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med. 334:1996;77-81.
8. Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, et al. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology. 25:1997;745-749.
9. Khorsi H, Castelain S, Wyseur A, Izopet J, Canva V, Rombout A, et al. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. J Hepatology. 27:1997;72-77.
10. Zeuzem S, Lee JH, Roth WK. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology. 25:1997;740-744.
11. Herion D, Hoofnagle JH. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same. Hepatology. 25:1997;769-771.
12. Maertens G, Stutver L. Genotypes and genetic variation of hepatitis C virus. Harrison TJ, Zuckerman AJ, . The Molecular Medicine of Viral Hepatitis. 1997;183-233 John Wiley & Sons Ltd, England.
13. Simmonds P. Review: Variability of hepatitis C virus. Hepatology. 21:1995;570-583.
14. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med. 60:1990;215-222.
15. Okamoto H, Kobata S, Tokita H, Inoue T, Woodfield GD, Holland PV, et al. A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene. J Virol Methods. 57:1996;31-45.
16. Smith DB, Pathirana S, Davidson F, Lawlor M, Power J, Yap PL, et al. The origin of hepatitis C virus genotypes. J Gen Virol. 78:1997;321-328.
17. Saitou N, Nei M. The neighbor-joining method: a new phylogenetic tree. Mol Biol Evol. 4:1987;406-425.
18. Ishida C, Matsumoto K, Fukuda K, Matsushita K, Shiraki H, Maeda Y. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens. J Clin Microbiol. 31:1993;936-940.
19. Wang YF, Brotman B, Andrus L, Prince AM. Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees. J Infect Dis. 173:1996;808-821.
20. Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, et al. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia. Hepatology. 24:1996;790-795.
21. Pozzato G, Kaneko S, Morreti M, Croce L, Franzin F, Unoura M, et al. Different genotypes of hepatitis C virus are associated with different severity of liver disease. J Med Virol. 43:1994;291-296.
22. Prati D, Capelli C, Zanella A, Mozzi F, Bosoni P, Pappalettera M, et al. Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology. 110:1996;178-183.
23. Silini E, Bottelli R, Asti M, Bruno S, Candusso ME, Brambilla S, et al. Hepatitis C virus genotypes and the risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology. 111:1996;199-205.
24. Yamada M, Kakumu S, Yoshioka K, Higashi Y, Tanaka K, Ishikawa T, et al. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci. 39:1994;234-239.
25. Mita E, Hayashi N, Kanazawa Y, Hagiwara H, Ueda K, Kasahara A, et al. Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. J Hepatol. 21:1994;468-473.
26. Serfaty L, Chazouilleres O, Poujol-Robert A, Morand-Joubert L, Dubois C, Chretien Y, et al. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study. Hepatology. 26:1997;776-779.